The company recently received 510(k) clearance from the Food and Drug Administration to market lateral access implants and plans to introduce these products later this year.
More Articles on Devices:
7 Recent Orthopedic Device Company Expansions & Agreements
U.S. Spine Market Worth $5.5B, $1.5B From Minimally Invasive Devices
Lanx Launches TIMBERLINE Lateral Interbody Spine Fusion Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
